Syneos Health (formerly INC Research) Director of Sales Salaries in Boulder
The average Syneos Health (formerly INC Research) Director of Sales in Boulder earns an estimated $232,588 annually, which includes an estimated base salary of $158,159 with a $74,429 bonus. Syneos Health (formerly INC Research) Director of Sales compensation is $19,691 less than the US average for a Director of Sales. Director of Sales salaries at Syneos Health (formerly INC Research) in Boulder can range from $117,338 - $287,000.
In Boulder, The Sales Department at Syneos Health (formerly INC Research) earns $15,556 more on average than the Finance Department.
Last updated 2 years ago.
- $158,159
- avg. base
- $74,429
- avg. bonus
Director of Sales Salaries at Syneos Health (formerly INC Research)
In Boulder, Directors of Sales earn $9,239 more than Directors of Sales.
Compensation at Syneos Health (formerly INC Research) by Department
In Boulder, The Sales Department averages $15,556 more than the Finance Department, and $5,369 less than the IT Department
Director of Sales Compensation by Gender (All Companies)
The average female Director of Sales at companies similar size to Syneos Health (formerly INC Research) reported making $239,762, while the average male Director of Sales at similar sized companies reported making $235,680.
Director of Sales Compensation by Ethnicity (All Companies)
The average Caucasian Director of Sales at companies similar size to Syneos Health (formerly INC Research) reported making $239,643, while the average Hispanic or Latino Director of Sales at similar sized companies reported making $204,180.
How Directors of Sales at Syneos Health (formerly INC Research) Rate Their Compensation
The majority of Directors of Sales at Syneos Health (formerly INC Research) believe they're compensated fairly. 100% of Directors of Sales at Syneos Health (formerly INC Research) say they receive annual bonuses, and the vast majority (74%) are satisfied with their benefits. See more compensation ratings at Syneos Health (formerly INC Research)
